Dofort Pharma Private Limited - Due diligence report

A 360° intelligence report on Dofort Pharma Private Limited: trust score, financial health, credit view, compliance, directors, growth and d…

2006-09-06 Ahmedabad, Gujarat Active Unlisted Active Compliant
Connect MCP
DP Dofort Pharma Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Dofort Pharma Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
94/100
Trust Score
Low Risk

Dofort Pharma Private Limited is assessed as Low Risk with a Trust Score of 94/100. Dofort Pharma Private Limited is an active private limited indian non-government company incorporated in 2006, operating in the Financial Services sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 01 Aug 2026 from the latest processed filings. Dofort Pharma Private Limited snapshot & full profile →

Overall Assessment CautionWeakNeutralGoodStrong Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
94/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
90/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
60/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
90/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 4 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 60/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
RAJAN PRIYAKANT PARIKH 01234567 Director 01/04/2018 6 yrs Approved
JAYANTILAL PATEL 01234567 Director 01/04/2018 6 yrs Approved
KIRIT CHIMANBHAI TULSIBHAI PATEL 01234567 Director 01/04/2018 6 yrs Approved
JAYESH JITENDRA PARIKH 01234567 Director 01/04/2018 6 yrs Approved
JAYANTI CHIMANBHAI PATEL 01234567 Director 01/04/2018 6 yrs Approved
  • 5 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2016 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
1 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 90 · Distress 90
Growth signals & trust indicators
Revenue acceleration: +38% over 3 year(s).
Latest year revenue grew 1.42.
Profit expanded 2.1x year-on-year.
Operating for 19+ years.
Active GST registration(s).
Distress signals & risk flags
No critical warning flags detected in the available data.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence95/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment79/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view91/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 3 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
07 Oct 2019
Director appointed
RAJAN PRIYAKANT PARIKH (Director)
28 Sep 2019
Director ceased
KIRIT CHIMANBHAI TULSIBHAI PATEL
Director ceased
JAYANTI CHIMANBHAI PATEL
26 Oct 2018
Director appointed
KIRIT CHIMANBHAI TULSIBHAI PATEL (Director)
Director appointed
JAYANTI CHIMANBHAI PATEL (Director)
Director ceased
BHANUBHAI GORDHANBHAI PATEL
30 Sep 2011
Director ceased
JAYESH JITENDRA PARIKH
01 Feb 2011
Director appointed
JAYESH JITENDRA PARIKH (Director)
26 Dec 2010
Director ceased
PRADYUMNAKUMAR RAJESHWAR PATEL
19 Mar 2009
Securities allotted
85000 Equity Shares Without Differential Rights - 1.79 cr raised
31 Mar 2008
Director ceased
RAJAN PRIYAKANT PARIKH
01 Dec 2007
Director ceased
JAYANTILAL PATEL
02 Feb 2007
Director appointed
JAYANTILAL PATEL (Director)
10

Key Observations

Auto-generated from the data above
Revenue grew 24% over the last 3 financial year(s).
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
5 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a dominant controlling stake as per the FY 2016 annual return.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Iifl Finance U28999MH1997PTC110615 Mumbai, Maharashtra, India
Suraiya Minerals & Chemicals Pvt Ltd U67190WB1939PTC009909 Kolkata, West Bengal, India
Vakharia Financial Services Limited U65910MH1995PLC085686 Mumbai, Maharashtra, India
Saikirpa Tradex Private Limited U51909DL2007PTC165063 New Delhi, Delhi, India
Mahendra Shipping Limited U61110DL1981PLC012573 New Delhi, Delhi, India
Future Vision Exim Private Limited U51311DL2003PTC119321 Delhi, Delhi, India
Pou Chong Properties Private Limited U45201WB1999PTC090465 Kolkata, West Bengal, India
Saraf Enterprises Private Limited U29219AP1990PTC011582 Visakhapatnam, Andhra Pradesh, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Dofort Pharma Private Limited before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Dofort Pharma Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 60/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 90/100, margin trends, ownership structure and peer set for Dofort Pharma Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 94/100, distress signals and MSME payment-delay disclosures - know whether Dofort Pharma Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Dofort Pharma Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Dofort Pharma Private Limited an active company?

Dofort Pharma Private Limited has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is Dofort Pharma Private Limited financially healthy?

Dofort Pharma Private Limited has a Financial Health Score of 90/100 (Low Risk) based on its filed financial statements.

Should I do business with Dofort Pharma Private Limited?

Its overall Trust Score is 94/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Dofort Pharma Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 5 active director(s) are on record.

Does Dofort Pharma Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Dofort Pharma Private Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to Dofort Pharma Private Limited?

Its Credit Risk Score is 60/100 (Moderate). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.